NCT02937233View on ClinicalTrials.gov

Zika Virus Purified Inactivated Vaccine (ZPIV) Accelerated Vaccination Schedule Study

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 8, 2016

Primary Completion Date

June 4, 2018

Study Completion Date

June 4, 2018

Conditions
Zika
Interventions
BIOLOGICAL

Zika Virus Purified Inactivated Vaccine

OTHER

Placebo

Trial Locations (1)

02215

Center for Virology and Vaccine Research Clinical Trials Unit, Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

Walter Reed Army Institute of Research (WRAIR)

FED

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Kathryn Stephenson

OTHER

NCT02937233 - Zika Virus Purified Inactivated Vaccine (ZPIV) Accelerated Vaccination Schedule Study | Biotech Hunter | Biotech Hunter